Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Childhood cerebral adrenoleukodystrophy (CCER), adrenomyeloneuropathy (AMN) and AMN with cerebral demyelination (AMN-C) are the main phenotypic variants of X-linked adrenoleukodystrophy (ALD). It is caused by mutations in the ABCD1 gene encoding a half-size peroxisomal transporter that has to dimerize to become functional. The biochemical hallmark of ALD is the accumulation of very-long-chain fatty acids (VLCFA) in plasma and tissues. However, there is no correlation between the ALD phenotype and the ABCD1 gene mutations or the accumulation of VLCFA in plasma and fibroblast from ALD patients. The absence of genotype-phenotype correlation suggests the existence of modifier genes. To elucidate the mechanisms underlying the phenotypic variability of ALD, we studied the expression of ABCD1, three other peroxisomal transporter genes of the same family (ABCD2, ABCD3 and ABCD4) and two VLCFA synthetase genes (VLCS and BG1) involved in VLCFA metabolism, as well as the VLCFA concentrations in the normal white matter (WM) from ALD patients with CCER, AMN-C and AMN phenotypes. This study shows that: (1) ABCD1 gene mutations leading to truncated ALD protein are unlikely to cause variation in the ALD phenotype; (2) accumulation of saturated VLCFA in normal-appearing WM correlates with ALD phenotype and (3) expression of the ABCD4 and BG1, but not of the ABCD2, ABCD3 and VLCS genes, tends to be correlated with the severity of the disease, acting early in the pathogenesis of ALD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the intact brain white matter of cALD patients, C26:0 is 1.5-fold higher than in “pure” AMN [155].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [155]
In the citing paper
“There is some evidence that the amount of VLCFAs may be directly related to the risk of developing inflammatory demyelination.115”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [115]
In the citing paper
“While for ABCD2, ABCD3, and ACSVL1 no significant differences in mRNA expression levels were found in brain tissues when comparing CALD and AMN”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [115]
In the citing paper
“an altered expression of ACSBG1 and ABCD4 mRNA was observed in normal appearing white matter of CALD patients.115”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [115]
In the citing paper
“In 2005, Asheuer and coworkers demonstrated that brain VLCFA levels in normal appearing white matter correlate with the clinical phenotype [34].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [34]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · cited 1×
“Total lipids were extracted using 2:1 (vol/vol) chloroform/methanol and the Folch method (63).”
MethodLock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 2×
“This study shows that: (1) ABCD1 gene mutations leading to truncated ALD protein are unlikely to cause variation in the ALD phenotype; (2) accumulation of saturated VLCFA in normal-appearing WM correlates with ALD phenotype and (3) expression of the ABCD4 and BG1, but not of the ABCD2, ABCD3 and VLCS genes, tends to b…”
BackgroundSelf-citationCholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16390 · Cited by 989 · cited 1×
“The formation of VLCFA-containing ChE could not only trap the VLCFA leading to increased levels, but also impair cellular processes at the plasma membrane by modifying the cholesterol/ChE ratio (51).”
BackgroundRecommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Cholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216390 · Cited by 916
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872 · cited 2×
“Rabbit anti-ionized calcium-binding adapter molecule 1 (Iba1) antibody (dilution 1:400, Imai, Japan (60)) was used to detect microglial activation.”
MethodMoser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596 · cited 2×
“The protective effects of the NMD pathway against the production of faulty proteins have been suggested or demonstrated in several other hereditary disorders, including b-thalassemia (40).”
BackgroundElongation of long-chain fatty acids
Leonard, A. E., Pereira, S. L., Sprecher, H., & Huang, Y.-S. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00040-7 · Cited by 584 · cited 2×
“The reduction of mono-unsaturated VLCFA observed in the WM from CCER and AMN-C patients may reflect substrate competition between saturated and mono-unsaturarted long chain fatty acids for the two elongases (ELOVL1 and ELOVL3) that display chain-length specificity toward VLCFA (36).”
BackgroundA family of fatty acid transporters conserved from mycobacterium to man
Hirsch, D., Stahl, A., & Lodish, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8625 · Cited by 450 · cited 1×
“Six full-length cDNAs that encode enzymes with very longchain acyl-CoA synthetase (VLACS) activity have been cloned (25).”
BackgroundHettema, E. H., van Roermund, C. W., Distel, B., van den Berg, M., Vilela, C., Rodrigues‐Pousada, C., Wanders, R. J., & Tabak, H. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00755.x · Cited by 323
Kemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. A., & Moser, H. W. (2001) · Human Mutation · doi:10.1002/humu.1227 · Cited by 321 · cited 1×
“With the exception of the delta26 mutation, this is consistent with the observation that all the frame shift, nonsense and insertion/deletion mutations of ABCD1 gene so far identified result in the absence of detectable levels of ALDP in fibroblasts (39).”
ResultA mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293
Self-citationHuman Gene Mutation Database?A biomedical information and research resource
Krawczak, M., Ball, E. V., Fenton, I., Stenson, P. D., Abeysinghe, S., Thomas, N., & Cooper, D. N. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<45::aid-humu10>3.0.co;2-t · Cited by 273
POWERS, J. M., LIU, Y., MOSER, A. B., & MOSER, H. W. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00007 · Cited by 265
Self-citationLagerstedt, S. A., Hinrichs, D. R., Batt, S. M., Magera, M. J., Rinaldo, P., & McConnell, J. P. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3170 · Cited by 259 · cited 1×
“VLCFA concentrations were measured/analyzed by gas chromatography/ mass spectrometry as described (64).”
MethodGene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D. (1998) · Nature Medicine · doi:10.1038/3242 · Cited by 249 · cited 1×
“The possible functional equivalence of the ABCD1 and ABCD2 genes has been repeatedly suggested (22,23).”
BackgroundSelf-citationMutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome
Gärtner, J., Moser, H., & Valle, D. (1992) · Nature Genetics · doi:10.1038/ng0492-16 · Cited by 226 · cited 1×
“ALDP belongs to a small family of ATP-binding cassette (ABC) peroxisomal transporters that includes three other members: ABCD2orALDR (ALD-related protein) (4),ABCD3orPMP70 (5) and ABCD4 or P70R (6,7).”
BackgroundLazo, O., Contreras, M., Hashmi, M., Stanley, W., Irazu, C., & Singh, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7647 · Cited by 218 · cited 3×
“VLCFA-synthetase activity is reduced in peroxisomes from ALD fibroblasts (26,27), and it has long been considered that the in vivo activity of this enzyme may play a role in the accumulation of VLCFA observed in ALD tissues.”
BackgroundWatkins, P. A. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00004-0 · Cited by 216 · cited 1×
“Activation of VLCFA to CoA derivatives by synthetases plays a pivotal role in directing VLCFA toward a specific metabolic fate, including degradation by peroxisomal b-oxidation, or incorporation into complex lipids (24).”
BackgroundPujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214
Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201 · cited 4×
“The ABCD2 gene is mainly expressed in neurons and its expression is not modified in the ALD mouse (23,41).”
BackgroundInfluentialHo, J. K., Moser, H., Kishimoto, Y., & Hamilton, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118182 · Cited by 199 · cited 2×
“VLCFA accumulation was shown to be detrimental to adrenocortical cells in culture (58) and to model membrane (59), but the pathogenic role of saturated VLCFA accumulation remains elusive.”
BackgroundKobayashi, T., Shinnoh, N., Kondo, A., & Yamada, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6340 · Cited by 197
X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes
Smith, K. D., Kemp, S., Braiterman, L. T., Lu, J.-F., Wei, H.-M., Geraghty, M., Stetten, G., Bergin, J. S., Pevsner, J., & Watkins, P. A. (1999) · Neurochemical Research · doi:10.1023/a:1022535930009 · Cited by 190 · cited 3×
“As expected from previous findings (19), no correlation was found between ABCD1 gene mutations and phenotype.”
Ewart, G. D., Cannell, D., Cox, G. B., & Howells, A. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34070-x · Cited by 173
Preventing Neurodegeneration in the Drosophila Mutant bubblegum
Min, K.-T., & Benzer, S. (1999) · Science · doi:10.1126/science.284.5422.1985 · Cited by 172 · cited 1×
“Min and Benzer (29) described a Drosophila melanogaster mutant, ‘bubblegum’, characterized by neurodegeneration and elevated levels of VLCFA.”
BackgroundWhitcomb, R. W., Linehan, W. M., & Knazek, R. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113292 · Cited by 168 · cited 1×
“VLCFA accumulation was shown to be detrimental to adrenocortical cells in culture (58) and to model membrane (59), but the pathogenic role of saturated VLCFA accumulation remains elusive.”
BackgroundWanders, R. J. A., van Roermund, C. W. T., van Wijland, M. J. A., Schutgens, R. B. H., van den Bosch, H., Schram, A. W., & Tager, J. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81140-9 · Cited by 158 · cited 3×
“VLCFA-synthetase activity is reduced in peroxisomes from ALD fibroblasts (26,27), and it has long been considered that the in vivo activity of this enzyme may play a role in the accumulation of VLCFA observed in ALD tissues.”
BackgroundBièche, I., Parfait, B., Doussal, V. L., Olivi, M., Rio, M. C., Lidereau, R., & Vidaud, M. (2001) · PubMed · Cited by 151
Self-citationNetik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148 · cited 1×
“The over-expression of ABCD3 also restores VLCFA ß-oxidation in human ALD fibroblasts and in the liver of ALD mouse, indicating that the functions of the PMP70 and ALDP overlap (43,44).”
BackgroundRole of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147
Homo- and Heterodimerization of Peroxisomal ATP-binding Cassette Half-transporters
Liu, L. X., Janvier, K., Berteaux-Lecellier, V., Cartier, N., Benarous, R., & Aubourg, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32738 · Cited by 141 · cited 1×
“Homo- and hetero-dimerization occurs in vitro among ALDP, ALDRP and PMP70 by using the yeast two-hybrid system and co-immunoprecipitation (18,19).”
MethodSelf-citationSpectrum of mutations in the gene encoding the adrenoleukodystrophy protein.
(1995) · Europe PMC (PubMed Central) · Cited by 130
PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene.
Shani, N., Watkins, P. A., & Valle, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6012 · Cited by 129
Berger, J., Molzer, B., Fae, I., & Bernheimer, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2855 · Cited by 126 · cited 1×
“identical mutations in the ABCD1 gene is highly variable, ranging from CCER to mild AMN even within the same family (8).”
BackgroundIdentification of a Fourth Half ABC Transporter in the Human Peroxisomal Membrane
Shani, N., Jimenez-Sanchez, G., Steel, G., Dean, M., & Valle, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1925 · Cited by 124 · cited 5×
“ALDP belongs to a small family of ATP-binding cassette (ABC) peroxisomal transporters that includes three other members: ABCD2orALDR (ALD-related protein) (4),ABCD3orPMP70 (5) and ABCD4 or P70R (6,7).”
BackgroundInfluentialThe neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
Dubois-Dalcq, M., Feigenbaum, V., & Aubourg, P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01319-8 · Cited by 121 · cited 2×
“This study shows that: (1) ABCD1 gene mutations leading to truncated ALD protein are unlikely to cause variation in the ALD phenotype; (2) accumulation of saturated VLCFA in normal-appearing WM correlates with ALD phenotype and (3) expression of the ABCD4 and BG1, but not of the ABCD2, ABCD3 and VLCS genes, tends to b…”
BackgroundSelf-citationPaintlia, A. S., Gilg, A. G., Khan, M., Singh, A. K., Barbosa, E., & Singh, I. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.013 · Cited by 120 · cited 2×
“However, a relationship does exist between the degree of VLCFA accumulation and the levels of inflammatory cytokine/gene expression in demyelinated areas (57).”
BackgroundBraiterman, L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.239 · Cited by 98 · cited 1×
“The over-expression of ABCD3 also restores VLCFA ß-oxidation in human ALD fibroblasts and in the liver of ALD mouse, indicating that the functions of the PMP70 and ALDP overlap (43,44).”
BackgroundElongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy
Kemp, S., Valianpour, F., Denis, S., Ofman, R., Sanders, R.-J., Mooyer, P., Barth, P. G., & Wanders, R. J. A. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.015 · Cited by 97 · cited 1×
“The saturated VLCFA that accumulate in ALD are mostly of endogenous origin (33,34) and elongation of saturated VLCFA is enhanced in ALD fibroblasts (35).”
BackgroundHolzinger, A., Kammerer, S., Berger, J., & Roscher, A. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7391 · Cited by 92 · cited 1×
“ALDP belongs to a small family of ATP-binding cassette (ABC) peroxisomal transporters that includes three other members: ABCD2orALDR (ALD-related protein) (4),ABCD3orPMP70 (5) and ABCD4 or P70R (6,7).”
BackgroundPrimary Structure of Human PMP69, a Putative Peroxisomal ABC-Transporter
Holzinger, A., Kammerer, S., & Roscher, A. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7102 · Cited by 91 · cited 5×
“ALDP belongs to a small family of ATP-binding cassette (ABC) peroxisomal transporters that includes three other members: ABCD2orALDR (ALD-related protein) (4),ABCD3orPMP70 (5) and ABCD4 or P70R (6,7).”
BackgroundInfluentialHeinzer, A. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg126 · Cited by 88
Bourre, J. M., Daudu, O., & Baumann, N. (1976) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(76)90043-6 · Cited by 78
Swartzman, E. E., Viswanathan, M. N., & Thorner, J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.4.549 · Cited by 77
Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo
Guimarães, C. P., Domingues, P. M., Aubourg, P. R., Fouquet, F., Pujol, A., Jiménez‐Sánchez, G., Sá-Miranda, C., & Azevedo, J. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.04.001 · Cited by 63 · cited 1×
“However, homodimerization of ALDP seems to prevail in vivo (20).”
BackgroundSelf-citationAdrenoleukodystrophy: Very long‐chain fatty acid metabolism in fibroblasts
Rizzo, W. B., Avigan, J., Chemke, J., & Schulman, J. D. (1984) · Neurology · doi:10.1212/wnl.34.2.163 · Cited by 60 · cited 1×
“The saturated VLCFA that accumulate in ALD are mostly of endogenous origin (33,34) and elongation of saturated VLCFA is enhanced in ALD fibroblasts (35).”
BackgroundBrown, F. R., Duyn, M. A. V., Moser, A. B., Schulman, J. D., Rizzo, W. B., Snyder, R. D., Murphy, J. V., Kamoshita, S., Migeon, C. J., & Moser, H. W. (1982) · PubMed · Cited by 56
Self-citationFlavigny, E., Sanhaj, A., Aubourg, P., & Cartier, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00379-8 · Cited by 49
Self-citationTagawa, Y., Laroy, W., Nimrichter, L., Fromholt, S., Moser, A. B., Moser, H. W., & Schnaar, R. L. (2002) · Neurochemical Research · doi:10.1023/a:1020221410895 · Cited by 35
Self-citationBoles, D. J., Craft, D. A., Padgett, D. A., Loria, R. M., & Rizzo, W. B. (1991) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(91)90010-i · Cited by 34 · cited 1×
“No correlation has been found between the phenotype and the levels of saturated VLCFA in ALD fibroblasts or lymphocytes (55,56).”
BackgroundMouse Very Long-chain Acyl-CoA Synthetase in X-linked Adrenoleukodystrophy
Heinzer, A. K., Kemp, S., Lu, J., Watkins, P. A., & Smith, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203053200 · Cited by 33 · cited 1×
“The absence of any change in the expression of the VLCS gene in the normal WM of CCER, AMN-C and AMN patients is similar to that observed in ALD mouse tissues (32,47).”
ResultX-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases
Jia, Z., Pei, Z., Li, Y., Wei, L., Smith, K. D., & Watkins, P. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.06.015 · Cited by 32 · cited 4×
“The absence of any change in the expression of the VLCS gene in the normal WM of CCER, AMN-C and AMN patients is similar to that observed in ALD mouse tissues (32,47).”
BackgroundResultInfluentialOgino, T., & Suzuki, K. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01657.x · Cited by 32 · cited 1×
“In human ALD brain, VLCFA accumulate in the cholesterol ester (ChE) fraction (1), and the rate of the reverse reaction is exceedingly low (50).”
BackgroundMurine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase
Fraisl, P., Forss‐Petter, S., Žigman, M., & Berger, J. (2004) · Biochemical Journal · doi:10.1042/bj20031062 · Cited by 30 · cited 1×
“The expression of the BG1 gene is not modified in the brain and spinal cord of the ALD mouse (32,49).”
BackgroundShani, N., Sapag, A., Watkins, P. A., & Valle, D. L. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18697.x · Cited by 29
ABCD1 translation–initiator mutation demonstrates genotype–phenotype correlation for AMN
O’Neill, G. N., Aoki, M., & Brown, R. H. (2001) · Neurology · doi:10.1212/wnl.57.11.1956 · Cited by 28
Schmidt, S., Marrosu, G. M., Kölsch, H., Haase, C. G., Ferenczik, S., Sokolowski, P., Köhler, W., Schmidt, M., Papassotiropoulos, A., Heun, R., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00445-9 · Cited by 8
Holzinger, A., Mayerhofer, P. U., Maier, E. M., Roscher, A. A., & Berger, J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_13 · Cited by 3 · cited 1×
“This is in agreement with the absence of ABCD2 allele/phenotype co-segregation in a large ALD kindred (42).”
ResultPaintlia, A. S. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.012 · Cited by 2
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Self-citationKordower (1999) · doi:10.1002/1531-8249(199909)46:3
Forss-Petter, S. (1997) · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
Research works printed but not linked: 4
- Steinberg, S.J., Kemp, S., Braiterman, L.T. and Watkins, P.A. (1999) Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy. Ann. Neurol., 46, 409–412. · doi:10.1002/1531-8249(199909)46:3<409::aid-ana18>3.0.co;2-9
- den Dunnen, J.T. and Antonarakis, S.E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat., 15, 7–12. · DOI · Paper page
- Silva-Zolezzi, I., Hebron, K., Mihalik, S., Thomas, G., Valle, D. and Jimenez-Sanchez, G. (2003) Abcd3−/− mice have a non-shivering thermogenesis defect related to a disturbance in fasting fuel homeostasis. Proceedings of the 53rd Annual Meeting of The American Society of Human Genetics. The American Society of Human Genetics, Los Angeles, California, Suppl. to Vol. 73, p. 199.
- Moser, A.B., Kreiter, N., Bezman, L., Lu, S., Raymond, G.V., Naidu, S. and Moser, H.W. (1999) Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol., 45, 100–110. · doi:10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u
Cited by
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283
“However, positive association studies with variants in genes involved in methionine metabolism [77,78], and SOD2 [79], or altered gene expression of Bubblegum (a member of the VLCFacyl-CoA synthetase family) [34], and ABCD4 (PMP69/P70R, another half ABC-transporter with high homology to ALDP) [34], might indicate thei…”
Self-citationPathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238
“Although VLCFA levels in blood or cultured fibroblasts are indistinguishable in X-ALD patients with different clinical phenotypes, the amounts of VLCFA were found to be higher in normal appearing white matter of CALD patients compared with AMN patients [65].”
ResultEarly oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214
“Also, there is no correlation between the ALD phenotype and the accumulation of VLCFA in plasma and fibroblasts from ALD patients, although a recent study suggests a link between the levels of VLCFA in white matter and disease severity (7).”
BackgroundTurk, B. R., Theda, C., Fatemi, A., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 210
“However, the amounts of VLCFA levels in normal appearing white matter were found to be higher in CALD compared with the levels in pure AMN (Asheuer et al., 2005).”
ResultSelf-citation
Metadata
- Authors
- Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., & Aubourg, P.
- Affiliations
- Inserm (FR)
- Corresponding author
- Asheuer, Muriel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-30
- Volume
- 14
- Issue
- 10
- Pages
- 1293-1303
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2168710549
- Cited by
- 86
- References
- 65
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 5 · 2013: 7 · 2012: 3
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association Européenne contre les Leucodystrophies
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- X-linked adrenoleukodystrophy, ABCD4, ABCD1, ABCD2, ABCD3, very long chain fatty acids, genotype-phenotype correlation, genetic modifiers, childhood cerebral adrenoleukodystrophy, adrenomyeloneuropathy, normal-appearing white matter, gene expression, disease severity
- MeSH terms
- Long-Chain-Fatty-Acid-CoA Ligase, Adrenoleukodystrophy, Brain, Cells, Cultured, Coenzyme A Ligases, Fibroblasts, Humans, Membrane Proteins, ATP-Binding Cassette Transporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.